Sangamo Therapeutics
SGMO
#8725
Rank
โ‚ฌ0.14 B
Marketcap
0,43ย โ‚ฌ
Share price
-6.45%
Change (1 day)
-77.11%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ76.13 Million

According to Sangamo Therapeutics 's latest financial reports the company's total assets are โ‚ฌ76.13 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sangamo Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ97.66 M-34.69%
2023-12-31โ‚ฌ0.14 B-71.48%
2022-12-31โ‚ฌ0.52 B-17.74%
2021-12-31โ‚ฌ0.63 B-16.46%
2020-12-31โ‚ฌ0.76 B34.08%
2019-12-31โ‚ฌ0.56 B10.27%
2018-12-31โ‚ฌ0.51 B115.95%
2017-12-31โ‚ฌ0.23 B59.21%
2016-12-31โ‚ฌ0.15 B-24.45%
2015-12-31โ‚ฌ0.19 B-0.65%
2014-12-31โ‚ฌ0.19 B96.09%
2013-12-31โ‚ฌ0.10 B63.45%
2012-12-31โ‚ฌ62.39 M-7.22%
2011-12-31โ‚ฌ67.25 M41.99%
2010-12-31โ‚ฌ47.36 M-22.39%
2009-12-31โ‚ฌ61.03 M25.75%
2008-12-31โ‚ฌ48.53 M-15.54%
2007-12-31โ‚ฌ57.46 M35.93%
2006-12-31โ‚ฌ42.27 M2.23%
2005-12-31โ‚ฌ41.34 M61.53%
2004-12-31โ‚ฌ25.59 M-30.29%
2003-12-31โ‚ฌ36.72 M-31.73%
2002-12-31โ‚ฌ53.78 M-44.13%
2001-12-31โ‚ฌ96.26 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
โ‚ฌ50.27 B 65,932.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ4.16 B 5,373.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ77.42 B 101,589.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ25.08 B 32,849.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚ฌ52.38 B 68,704.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ165.60 B 217,419.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ6.54 B 8,490.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ111.26 B 146,043.52%๐Ÿ‡บ๐Ÿ‡ธ USA